We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+18.99%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$215M
AUM Growth
+$24.1M
Cap. Flow
-$836K
Cap. Flow %
-0.39%
Top 10 Hldgs %
45.09%
Holding
99
New
7
Increased
8
Reduced
43
Closed
5

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.21M
2
HPQ icon
HP
HPQ
+$2.38M
3
ED icon
Consolidated Edison
ED
+$685K
4
BSX icon
Boston Scientific
BSX
+$614K
5
CLX icon
Clorox
CLX
+$569K

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$3.56M
2
MDT icon
Medtronic
MDT
+$802K
3
GEHC icon
GE HealthCare
GEHC
+$678K
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$524K
5
GS icon
Goldman Sachs
GS
+$442K

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Financials 20.8%
3 Industrials 18.51%
4 Healthcare 13.82%
5 Communication Services 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OKE icon
26
Oneok
OKE
$57.2B
$3.18M 1.48%
36,530
-572
-2% -$50.4K
AMGN icon
27
Amgen
AMGN
$208B
$2.69M 1.25%
7,427
-165
-2% -$56.5K
JKHY icon
28
Jack Henry & Associates
JKHY
$10.9B
$2.58M 1.2%
18,755
-375
-2% -$53.2K
CVS icon
29
CVS Health
CVS
$133B
$2.47M 1.15%
23,870
-495
-2% -$44.2K
HPQ icon
30
HP
HPQ
$24.9B
$2.36M 1.1%
+107,477
New +$2.38M
MLM icon
31
Martin Marietta Materials
MLM
$31.5B
$2.29M 1.06%
3,963
– –
V icon
32
Visa
V
$684B
$2.22M 1.03%
6,463
-249
-4% -$79.9K
LYB icon
33
LyondellBasell Industries
LYB
$20B
$2.18M 1.01%
41,470
-1,050
-2% -$72.5K
LMT icon
34
Lockheed Martin
LMT
$134B
$2.13M 0.99%
4,180
-170
-4% -$91.9K
MSFT icon
35
Microsoft
MSFT
$3.45T
$2.11M 0.98%
5,653
+70
+1% +$28.3K
JNJ icon
36
Johnson & Johnson
JNJ
$618B
$2.06M 0.96%
8,092
-249
-3% -$58K
FFIV icon
37
F5
FFIV
$22.9B
$1.91M 0.89%
4,580
-270
-6% -$95.9K
VRTX icon
38
Vertex Pharmaceuticals
VRTX
$121B
$1.87M 0.87%
3,761
-235
-6% -$104K
BAM icon
39
Brookfield Asset Management
BAM
$77.3B
$1.8M 0.84%
40,091
-4,713
-11% -$223K
META icon
40
Meta Platforms (Facebook)
META
$1.42T
$1.44M 0.67%
2,554
-75
-3% -$45.9K
J icon
41
Jacobs Solutions
J
$15.9B
$1.29M 0.6%
10,279
– –
MRK icon
42
Merck
MRK
$322B
$1.27M 0.59%
9,883
-145
-1% -$17K
WFC icon
43
Wells Fargo
WFC
$261B
$1.23M 0.57%
14,838
– –
CI icon
44
Cigna
CI
$73.7B
$1.22M 0.57%
4,437
-273
-6% -$77.1K
ORCL icon
45
Oracle
ORCL
$374B
$1.09M 0.51%
7,421
– –
CARR icon
46
Carrier Global
CARR
$51B
$1.02M 0.48%
13,962
-333
-2% -$21.8K
KLAC icon
47
KLA
KLAC
$239B
$905K 0.42%
3,000
– –
BKNG icon
48
Booking.com
BKNG
$149B
$829K 0.39%
4,650
+1,275
+38% +$218K
NVDA icon
49
NVIDIA
NVDA
$4.86T
$791K 0.37%
3,951
– –
VZ icon
50
Verizon
VZ
$195B
$706K 0.33%
16,683
– –
1
2
3 4

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Lipe & Dalton's Q2 2026 Portfolio in Review

As of Q2 2026, Lipe & Dalton held 99 positions worth $215M, up 13% from $191M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Lipe & Dalton's Q2 2026 filing shows 7 new, 8 increased, 43 reduced and 5 closed positions. Its largest new stake was HP: 107,477 shares worth $2.36M. The largest sale was Intel, an estimated $3.56M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Lipe & Dalton's largest Q2 2026 buy was HP: 107,477 shares worth $2.36M.
  • Lipe & Dalton added most to Berkshire Hathaway Class B in Q2 2026, an estimated $4.21M increase.
  • Lipe & Dalton's biggest Q2 2026 reduction was Intel, cutting an estimated $3.56M.
  • Lipe & Dalton fully exited Medtronic in Q2 2026, selling an estimated $802K.
  • Lipe & Dalton's ten largest holdings make up 45% of its $215M portfolio in Q2 2026.
  • Lipe & Dalton opened 7 new positions and closed 5 in Q2 2026.
  • Lipe & Dalton's portfolio value rose 13% quarter-over-quarter to $215M.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.